Safety and drug effects of AD-230 in healthy adults
Part of Digestive system clinical trials.
This early-phase trial tests a new investigational drug called AD-230 in healthy adults. The main goal is to understand how the body processes the drug, check its safety, and see how food affects it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult aged 19 to 64.
- Your body mass index (BMI) must be between 18.5 and 29.9.
- You cannot have taken part in another clinical study with an investigational drug in the last 6 months.
- Other additional exclusions may apply, so the study team will review your full medical history.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new drug called AD-230 in healthy adults to see how the body absorbs and processes it and to check for safety. You will help researchers learn important information before the drug is tested in patients.
This study tests a new medicine called AD-231 and compares it to taking three separate pills together. You would need to be in generally good health and within a certain age and weight range.
This trial tests how three study drugs interact with each other in healthy adults. It may help find safe doses for future treatments.
This study tests how two experimental medications (AD-236A and AD-236B) interact with each other in the body and checks that they are safe for healthy adults. It helps determine how these drugs should be dosed for future treatments.
This trial tests how two study drugs, AD-2321 and AD-2322, interact with each other in the body and checks if they are safe for healthy adults. Taking part will help researchers learn more about these drugs for future use.
This trial tests a new drug called AD-123 and compares it to taking two other drugs (AD-1231 and AD-1232) together. It is for healthy adults to see how the body handles the drugs and if they are safe.
Hear when a new Chronic Liver Disease (CLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.